Previously published data generated from serial dilutions of RNA derived from ALL or CML cell lines (TOM-1 or K-562) demonstrated that the Q-LAMP assay detected and discriminated the p190 (e1a2) and p210 (e13a2 and e14a2) BCR-ABL1 transcripts within 50 min. The gene discussed is EVPL; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.